The Current Ratio as of November 2024 (TTM) for InVitro International (IVRO) is 30.23

According to InVitro International’s latest financial reports and current stock price. The company's current Current Ratio is 30.23. This represents a change of 22.55% compared to the average of 24.66 of the last 4 quarters.

InVitro International (IVRO) Historical Current Ratio (quarterly & annually)

How has IVRO Current Ratio performed in the past?

The mean historical Current Ratio of InVitro International over the last ten years is 12.07. The current 30.23 Current Ratio has changed 24.95% with respect to the historical average. Over the past ten years (40 quarters), IVRO's Current Ratio was at its highest in in the March 2023 quarter at 31.13. The Current Ratio was at its lowest in in the December 1991 quarter at 0.

InVitro International (IVRO) Current Ratio by Quarter and Year

Discovering the peaks and valleys of InVitro International Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

InVitro International (IVRO) Average Current Ratio

How has IVRO Current Ratio performed in the past?

The current Current Ratio of InVitro International (IVRO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

InVitro International (IVRO) Current Ratio vs. Peers

How is IVRO’s Current Ratio compared to its peers?

InVitro International’s Current Ratio is greater than Izotropic Corporation (0.05), greater than Biodesix, Inc. (3.40), greater than Neuronetics, Inc. (3.16), greater than Star Equity Holdings, Inc. (2.01), greater than Burning Rock Biotech Limited (3.11), greater than DarioHealth Corp. (0), greater than Genetron Holdings Limited (0), greater than Sera Prognostics, Inc. (2.11), greater than Olink Holding AB (publ) (5.60), greater than Exagen Inc. (4.05), greater than VolitionRx Limited (0.22), greater than Intelligent Bio Solutions Inc. (1.14), greater than bioAffinity Technologies, Inc. (1.02), greater than SeqLL Inc. (0.91), greater than HTG Molecular Diagnostics, Inc. (1.89), greater than T2 Biosystems, Inc. (0.40), greater than Biocept, Inc. (2.97), greater than iSpecimen Inc. (0.74),

Build a custom stock screener for InVitro International (IVRO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like InVitro International using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

InVitro International (IVRO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like InVitro International or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.